Scott Dunseth Myers's Net Worth

$4.43 Million

Estimate Recalculated Nov 1, 2024 10:35AM EST

Who is Scott Dunseth Myers

Scott Dunseth Myers has an estimated net worth of $4.43 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., DYNAVAX TECHNOLOGIES CORP, Harpoon Therapeutics, Inc., SELECTA BIOSCIENCES INC, Trillium Therapeutics Inc., AMAG PHARMACEUTICALS, INC., Viridian Therapeutics, Inc.\DE, and DOV PHARMACEUTICAL INC.

SEC CIK

Scott Dunseth Myers's CIK is 0001356256

Past Insider Trading and Trends

2023 was Scott Dunseth Myers's most active year for acquiring shares with 12 total transactions. Scott Dunseth Myers's most active month to acquire stocks was the month of April. 2018 was Scott Dunseth Myers's most active year for disposing of shares, totalling 10 transactions. Scott Dunseth Myers's most active month to dispose stocks was the month of February. 2023 saw Scott Dunseth Myers paying a total of $261,803.25 for 1,502,213 shares, this is the most they've acquired in one year. In 2023 Scott Dunseth Myers cashed out on 207,500 shares for a total of $81,375.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncothyreon Inc.

President and CEO
Updated Mar 13, 2018
Form 4
-100.00%
-1.10M
Mar 13, 2018
Disposition
Mar 09
Form 4
250.00K
Feb 02, 2018
250.00K
Grant
Feb 01
Form 4
-3.74%
-3.43K
$3.92
-$13.44K
Jan 16, 2018
88.29K
Options
Jan 11
Form 4
6.30K
Nov 13, 2017
6.30K
Grant
Nov 10
Form 4
75.50K
Sep 20, 2017
75.50K
Grant
Sep 18
Form 4
12.44%
5.50K
$3.74
$20.54K
Aug 14, 2017
49.72K
Purchase
Aug 11
Form 4
6.76%
2.80K
$4.00
$11.19K
May 16, 2017
44.22K
Purchase
May 12
Form 4
5.07%
2.00K
$4.11
$8.23K
Apr 04, 2017
41.42K
Purchase
Mar 31
Form 4
2.60%
1.00K
$3.93
$3.93K
Mar 21, 2017
39.42K
Purchase
Mar 20
Form 4
114.42%
20.50K
$3.76
$77.04K
Jan 31, 2017
38.42K
Purchase
Jan 27
Form 4
232.00K
Jan 13, 2017
232.00K
Grant
Jan 11
Form 4
72.00%
45.00K
$1.15
$51.75K
Aug 18, 2016
107.50K
Purchase
Aug 17
Form 4
62.50K
$0.80
$50.00K
Jun 28, 2016
62.50K
Purchase
Jun 28
Form 4
2.85M
Apr 06, 2016
2.85M
Grant
Apr 04
Form 3
Apr 06, 2016
Showing 15 results

DYNAVAX TECHNOLOGIES CORP

Investor
Updated May 28, 2024
Form 4
138.67%
27.86K
May 28, 2024
47.95K
Grant
May 23
Form 4
189.09%
27.86K
May 31, 2023
42.59K
Grant
May 26
Form 4
20.89K
May 27, 2022
20.89K
Grant
May 26
Form 4
55.71K
Oct 21, 2021
55.71K
Grant
Oct 19
Form 3
Oct 21, 2021
Showing 5 results

Harpoon Therapeutics, Inc.

Investor
Updated Mar 11, 2024
Form 4
-100.00%
-29.30K
Mar 11, 2024
Disposition
Mar 11
Form 4
9.93%
2.05K
Jan 03, 2024
22.67K
Grant
Jan 01
Form 4
32.01%
5.00K
Nov 28, 2023
20.62K
Grant
Nov 27
Form 4
59.03%
5.80K
Oct 02, 2023
15.62K
Grant
Oct 01
Form 4
56.94%
35.63K
Jul 06, 2023
98.22K
Grant
Jul 01
Form 4
46.00K
Jun 23, 2023
46.00K
Grant
Jun 22
Form 4
126.28%
34.92K
Apr 04, 2023
62.58K
Grant
Apr 01
Form 4
20.33K
Jun 24, 2022
20.33K
Grant
Jun 22
Form 4
10.17K
Oct 26, 2021
10.17K
Grant
Oct 25
Form 4/A
10.17K
May 14, 2021
10.17K
Grant
May 04
Form 4
10.17K
May 07, 2021
10.17K
Grant
May 04
Form 4
10.17K
Jun 01, 2020
10.17K
Grant
May 28
Form 4
10.17K
Jun 05, 2019
10.17K
Grant
Jun 03
Form 3
Feb 07, 2019
27.66K
Showing 14 results

SELECTA BIOSCIENCES INC

Investor
Updated Nov 15, 2023
Form 4
-100.00%
-207.50K
$0.93
-$81.37K
Nov 15, 2023
Disposition
Nov 13
Form 4
87.50K
Jan 04, 2023
87.50K
Grant
Jan 02
Form 4
40.00K
Jan 05, 2022
40.00K
Grant
Jan 03
Form 4
40.00K
Apr 01, 2021
40.00K
Grant
Mar 30
Form 4
20.00K
Jun 23, 2020
20.00K
Grant
Jun 19
Form 4
142.66%
59.11K
$0.79
$60.00K
Dec 26, 2019
100.55K
Grant
Dec 23
Form 4
41.44K
$1.81
$75.00K
Aug 20, 2019
41.44K
Grant
Aug 20
Form 4
20.00K
Jun 18, 2019
20.00K
Grant
Jun 14
Form 3
Jun 18, 2019
Showing 9 results

Trillium Therapeutics Inc.

Investor
Updated Nov 19, 2021
Form 4
-100.00%
-67.00K
Nov 19, 2021
Disposition
Nov 17
Form 4
67.00K
May 05, 2021
67.00K
Grant
May 03
Form 3
May 05, 2021
Showing 3 results

AMAG PHARMACEUTICALS, INC.

President & CEO
Updated Nov 17, 2020
Form 4
-100.00%
-1.00M
Nov 17, 2020
Disposition
Nov 16
Form 4
1.00M
Apr 30, 2020
1.00M
Grant
Apr 28
Form 3
Apr 30, 2020
Showing 3 results

Viridian Therapeutics, Inc.\DE

Chief Executive Officer
Updated Apr 12, 2023
Form 4
1.57%
4.00K
$25.37
$101.48K
Apr 12, 2023
259.50K
Purchase
Apr 12
Form 4
2.20%
5.50K
$29.15
$160.32K
Mar 13, 2023
255.50K
Purchase
Mar 13
Form 4
1.25M
Feb 07, 2023
1.25M
Grant
Feb 06
Form 3
Feb 07, 2023
Showing 4 results

DOV PHARMACEUTICAL INC

Senior Vice President
Updated Jun 30, 2006
Form 4
17.54%
50.00K
$2.08
$104.00K
Jun 30, 2006
335.00K
Grant
Jun 28
Form 4
10.00K
$2.69
$26.90K
May 26, 2006
10.00K
Purchase
May 24 - May 25
Showing 2 results